September 6, 2022
University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers published new findings on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments in the journal PLOS ONE.
August 30, 2022
The Guardian featured University of Cincinnati researcher Erica Birkley in an article on the effect of Americans halting COVID precautions on vulnerable populations.
August 24, 2022
Radiology Business highlighted the research of the University of Cincinnati's Prashanth Ravi and Frank Rybicki that found an in-house 3D print shop saved almost $3,000 per patient in operating-room costs thanks to shortened procedure times.
August 18, 2022
Design World featured the University of Cincinnati's Frank Rybicki in an article about different ways CAD and 3-D printing have helped advance medical care.
August 17, 2022
The University of Cincinnati's Michael Hegener, PharmD, was a panelist on WVXU's Cincinnati Edition discussing the under-regulated dietary supplements industry.
August 15, 2022
The University of Cincinnati's Elizabeth Shaughnessy, MD, PhD, joined 55KRC's Simply Medicine program to discuss breast cancer survivorship and screening in light of the recent death of actress and singer Olivia Newton-John.
August 12, 2022
The University of Cincinnati's Alberto Espay, MD, joined WVXU's Cincinnati Edition to discuss recent allegations that a key 2006 Alzheimer's study from the University of Minnesota may have been fabricated.
August 11, 2022
The University of Cincinnati's Joseph Broderick, MD, provided comments in a TCTMD article reviewing the results of a recent study that found administering the drug tirofiban before endovascular thrombectomy does not improve functional outcomes in patients.
August 10, 2022
Medium featured the research of the University of Cincinnati's Jiajie Diao, PhD, who recently published a paper showing early results that light-activated proteins can help normalize dysfunction within cells.
August 10, 2022
University of Cincinnati researchers Jason Gardner and Matthew Robson are studying whether targeting an inflammation pathway that affects burns and traumatic brain injuries can be an effective treatment for both conditions.